These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 14748759)

  • 1. Gemcitabine-induced severe pulmonary toxicity.
    Barlési F; Villani P; Doddoli C; Gimenez C; Kleisbauer JP
    Fundam Clin Pharmacol; 2004 Feb; 18(1):85-91. PubMed ID: 14748759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal pulmonary toxicity resulting from treatment with gemcitabine.
    Pavlakis N; Bell DR; Millward MJ; Levi JA
    Cancer; 1997 Jul; 80(2):286-91. PubMed ID: 9217042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical case of the month. Pulmonary toxicity due to gemcitabine for NSCLC with brain metastasis].
    Mommens V; Bosquée L; D'Orio V
    Rev Med Liege; 2003 Mar; 58(3):123-6. PubMed ID: 12723505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Severe interstitial pneumonitis related to Gemcitabine].
    Sabria-Trias J; Bonnaud F; Sioniac M
    Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine-induced pulmonary toxicity: case report and review of the literature.
    Gupta N; Ahmed I; Steinberg H; Patel D; Nissel-Horowitz S; Mehrotra B
    Am J Clin Oncol; 2002 Feb; 25(1):96-100. PubMed ID: 11823707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine-related pulmonary toxicity.
    Joerger M; Gunz A; Speich R; Pestalozzi BC
    Swiss Med Wkly; 2002 Jan; 132(1-2):17-20. PubMed ID: 11901447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine-induced systemic capillary leak syndrome.
    De Pas T; Curigliano G; Franceschelli L; Catania C; Spaggiari L; de Braud F
    Ann Oncol; 2001 Nov; 12(11):1651-2. PubMed ID: 11822767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe pulmonary toxicity in a patient treated with gemcitabine.
    Rosado MF; Kett DH; Schein RM; Baraona FJ; Sridhar KS
    Am J Clin Oncol; 2002 Feb; 25(1):31-3. PubMed ID: 11823691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of gemcitabine toxicity with a brief course of oral corticosteroid therapy.
    Vander Els NJ; Miller V
    Chest; 1998 Dec; 114(6):1779-81. PubMed ID: 9872221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine for lung cancer.
    Drug Ther Bull; 1996 Sep; 34(9):71-2. PubMed ID: 8885499
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity of gemcitabine in non-small-cell lung cancer: results of the Japan gemcitabine group (A) phase II study.
    Takada M; Negoro S; Kudo S; Furuse K; Nishikawa H; Takada Y; Kamei T; Niitani H; Fukuoka M
    Cancer Chemother Pharmacol; 1998; 41(3):217-22. PubMed ID: 9443638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe acute lung injury induced by gemcitabine.
    Linskens RK; Golding RP; van Groeningen CJ; Giaccone G
    Neth J Med; 2000 Jun; 56(6):232-5. PubMed ID: 10821980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interstitial lung disease in a patient given gemcitabine].
    Hammerer V; Schmitz N; Pauli G; Quoix E
    Rev Pneumol Clin; 2002 Feb; 58(1):23-6. PubMed ID: 11981501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal pulmonary toxicity resulting from treatment with gemcitabine.
    Tempero MA; Brand R
    Cancer; 1998 May; 82(9):1800-1. PubMed ID: 9576306
    [No Abstract]   [Full Text] [Related]  

  • 15. High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study.
    Kouroussis C; Mavroudis D; Kakolyris S; Voloudaki A; Kalbakis K; Souglakos J; Agelaki S; Malas K; Bozionelou V; Georgoulias V
    Lung Cancer; 2004 Jun; 44(3):363-8. PubMed ID: 15140550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of non-small cell lung cancer accompanied with hemorrhage after chemotherapy including gemcitabine].
    Nagashima O; Tajima K; Ito J; Kajiyama Y; Shimanuki Y; Miura K; Sato K; Miyamoto H; Uekusa T; Suzuki T; Takahashi K; Fukuchi Y
    Nihon Kokyuki Gakkai Zasshi; 2006 Mar; 44(3):215-9. PubMed ID: 16617866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of single-agent gemcitabine in advanced non-small cell lung cancer: a review.
    Hansen HH; Sørensen JB
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-38-S7-41. PubMed ID: 9194478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An autopsy case of acute pulmonary toxicity associated with gemcitabine.
    Maniwa K; Tanaka E; Inoue T; Kato T; Sakuramoto M; Minakuchi M; Maeda Y; Noma S; Kobashi Y; Taguchi Y
    Intern Med; 2003 Oct; 42(10):1022-5. PubMed ID: 14606719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety profile of gemcitabine, a novel anticancer agent, in non-small cell lung cancer.
    Cortes-Funes H; Martin C; Abratt R; Lund B
    Anticancer Drugs; 1997 Jul; 8(6):582-7. PubMed ID: 9300572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.